Sterne Agee Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$4.87M Sell
74,781
-1,117
-1% -$69.9K 0.72% 29
2014
Q4
$4.48M Buy
75,898
+491
+0.7% +$27.7K 0.69% 32
2014
Q3
$3.88M Buy
75,407
+5,499
+8% +$275K 0.62% 40
2014
Q2
$3.39M Buy
69,908
+39,648
+131% +$1.95M 0.57% 53
2014
Q1
$1.57M Buy
30,260
+57
+0.2% +$3.03K 0.31% 114
2013
Q4
$1.6M Buy
30,203
+878
+3% +$44.7K 0.53% 49
2013
Q3
$1.36M Sell
29,325
-25,813
-47% -$1.13M 0.53% 50
2013
Q2
$2.46M Buy
+55,138
New +$2.39M 0.88% 24

Other funds holding BMY

Sterne Agee Group's BMY Position: Q1 2015 in Review

Sterne Agee Group reduced its Bristol-Myers Squibb (BMY) stake by 1.5% in Q1 2015, selling an estimated $69.9K and leaving 74,781 shares worth $4.87M. The position accounts for 0.72% of the portfolio, ranked #29.

Sterne Agee Group first reported a position in BMY in Q2 2013 and has held it in 8 quarters since. 1,448 funds tracked by Wall St. Rank hold BMY as of Q1 2015.

  • Sterne Agee Group held 74,781 shares of Bristol-Myers Squibb worth $4.87M as of Q1 2015.
  • Sterne Agee Group sold 1,117 Bristol-Myers Squibb shares in Q1 2015, an estimated $69.9K.
  • Bristol-Myers Squibb made up 0.72% of Sterne Agee Group's portfolio in Q1 2015, its #29 holding.
  • Sterne Agee Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 8 quarters since.
  • 1,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2015.

Based on Sterne Agee Group's 13F filing for Q1 2015, filed 13 May 2015.